Villa World Ltd Delivered 2018 NPAT at the top end of company’s guidance

2018 NPAT at the top end of company’s guidance: Villa World Ltd.’s (ASX: VLW) stock rose 3.68% on August 15, 2018 after the company for FY 18 reported 15% growth in the statutory net profit after tax to $43.6 million, which is at the top end of company’s guidance of NPAT expected to be between $42 million and $44 million. The company has posted 39% rise in sales to 1,678 and the average sales rate increased to 140 per month from 101 per month in FY17, due to a strong full year contribution from flagship projects released in FY17 and Lilium that was launched in early 2Q18.

[optin-monster-shortcode id=”wxhmli4jjedneglg1trq”]

As a result, the company has posted the revenue of $441.6 million in 2018 compared to $386.8 million in FY17. The company has carried forward 845 sale contracts with a gross value of $278.1 million compared to 526 contracts worth $175.7 million in FY17.

Additionally, for FY 19, VLW expects statutory profit after tax of approximately $40 million. The company expects paying total dividends of 18.5 cents per share fully franked in FY19. The 1H19 dividend is expected to be 8 cps. On the other hand, VLW stock has fallen 13.20% in three months as on August 14, 2018  and is trading at a P/E of 7.56x.

Dividend Stocks To Buy

The Income available from dividends remains attractive for many investors.

We take a look at the best yields on the market and assess what they say about a company’s prospect.

One Thing is certain, though, Australia interest rates are still low, making income difficult to come by and keeping the focus for many investors on high yielding stocks. Kalkine’s team of analysts bought you handpicked report for “Top 25 Dividend Stocks For 2018.”

ASX-relevant Special Reports are published year-round to provide a detailed analysis into an investing opportunity or a potential risk to your portfolio.

Click here to get your free report.


The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. and associated websites are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). website), employees and/or associates of Kalkine Pty Ltd do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.

Checkout our Free Dividend Stocks Report

Specially made for income-hungry investors, Invest in growing Franked Dividends an opportunity that should not be missed.

6 Cannabis Stocks under Investor’s Limelight…

Cannabis companies that sell both medicinal weed and recreational pot. Marijuana stocks to look at. Marijuana mergers and acquisitions. Dispensary data analytics. Upcoming marijuana IPO’s Those phrases have become increasingly common as marijuana legalization spreads.

Global spending on legal cannabis is expected to grow 230% to $32 billion in 2020 as compared to $9.5 in 2017, according to Arcview Market Research and BDS Analytics. As of June 29, 2018 the United States Marijuana Index, despite a lot of uncertainty around regulations, has over the past 1 year gained 71.49%, as compared to about 12% gain seen by the S&P 500.

Click here for your FREE Report